` Comparison: ASPHF, GILD - Alpha Spread

ASPHF
vs
GILD

Over the past 12 months, ASPHF has outperformed GILD, delivering a return of +31% compared to the GILD's +29% growth.

Start AI Comparison

Smart Verdict
AI-Powered

Not Sure Which Stock Wins?
Let AI Decide.
ASPHF
GILD
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Smart Verdict is Ready!
See Who Stands Out.
All the numbers, charts, and metrics summarized into one smart verdict.
Stocks Compared:
Show Comparison Results
Summarizing...
We need a little more time to summarize the results

Valuation Comparison

ASPHF Intrinsic Value
12.07 USD
Undervaluation 30%
Intrinsic Value
Price
GILD Intrinsic Value
118.74 USD
Undervaluation 1%
Intrinsic Value
Price
Company Last Price Intrinsic Value DCF Value Relative Value Wall St Target
Ascentage Pharma Group International
OTC:ASPHF
8.48 USD
Gilead Sciences Inc
NASDAQ:GILD
117.32 USD
No Stocks Selected

Compare the stock's valuation with its competitors.

Select Stocks to Compare
Valuation Scenario:
Bear Case
Base Case
Bull Case

Growth Comparison

Growth Over Time
ASPHF, GILD

ASPHF
GILD
Add Stock
Revenue
www.alphaspread.com
No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare
Company LTM Historical Growth Growth Streak % Positive Years Max Drawdown Volatility Forecasted Growth
3 Years 5 Years 10 Years 1 Year 3 Years
Ascentage Pharma Group International
Revenue
Gilead Sciences Inc
Revenue

All metrics are calculated based on data from the last 10 years.

No Stocks Selected

Compare company's financials with its competitors.

Select Stocks to Compare

Profitability Comparison

Free Cash Flow
ASPHF, GILD

ASPHF
GILD
Add Stock
Free Cash Flow
www.alphaspread.com
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
Company LTM Average Historical Growth FCF Margin Conversion
3 Years 5 Years 3 Years 5 Years 10 Years
Ascentage Pharma Group International
OTC:ASPHF
Gilead Sciences Inc
NASDAQ:GILD
No Stocks Selected

Compare company's free cash flow with its competitors.

Select Stocks to Compare
What is Free Cash Flow?

Gross Margin

ASPHF
90.9%
GILD
78.7%

Operating Margin

ASPHF
-295.2%
GILD
39%

Net Margin

ASPHF
-296.8%
GILD
27.9%

FCF Margin

ASPHF
-55.5%
GILD
33.2%

ROE

ASPHF
-161.9%
GILD
40.6%

ROA

ASPHF
-37.7%
GILD
14.4%

ROIC

ASPHF
-73.3%
GILD
19%

ROCE

ASPHF
-59.9%
GILD
25.5%

Solvency Comparison

No Stocks Selected

Compare company's equity waterfall with its competitors.

Select Stocks to Compare
Balance Sheet Comparison
No Stocks Selected

Compare company's balance sheet with its competitors.

Select Stocks to Compare

Stocks Performance

Stocks Performance
ASPHF, GILD

Loading
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare

Performance Gap
ASPHF, GILD

Loading
ASPHF
GILD
Difference
www.alphaspread.com

Performance By Year
ASPHF, GILD

Loading
ASPHF
GILD
Add Stock
No Stocks Selected

Compare the stock's returns with its benchmark index and competitors. Gain insights into its relative performance over time.

Select Stock to Compare
Not Sure Which Stock Wins?
Let AI Decide
One-click summary across all key metrics.
Ranked results with clear takeaways.
No spreadsheets, no guesswork.
Start AI Comparison
Compare ASPHF to other stocks
Unlock Full Access to Alpha Spread
Create Free Account